FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test

The U.S. Food and Drug Administration today granted the first waiver to allow a nucleic acid-based test, the Alere i Influenza A B test, to be used in a greater variety of health care settings. The test was previously only available for use in certain laboratories.
Influenza, commonly known as…
FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: